This buyback disclosure is routine and non-material. Focus remains on pipeline catalysts for gamgertamig and any upcoming clinical data readouts. No immediate trading action warranted.
Price Chart
Executive Summary
Lakefront Biotherapeutics disclosed the repurchase of 127,796 of its own shares between August 24-28, 2026, for a total of €3.22M at an average price of €25.19 per share, as part of a buyback program announced on June 9, 2026. Post-repurchase, the company holds 1,161,324 treasury shares. This is a routine, small-scale buyback disclosure with no material impact on fundamentals or valuation.
Key Facts
- Repurchased 127,796 shares between August 24-28, 2026 at an average price of €25.19 per share.
- Total consideration was €3,218,710.15 across multiple European exchanges (XAMS, TQEX, CEUX, AQEU).
- As of August 28, 2026, the company holds 1,161,324 of its own ordinary shares.
- Buyback program was originally announced on June 9, 2026.
- Pipeline anchored by gamgertamig (BCMAxCD3 T-cell engager) for autoimmune diseases — the only clinical-stage candidate mentioned.
Financial Impact
€3.22M repurchase represents ~0.17% of LKFT's $1.9B market cap — trivial capital allocation signal
Risk Factors
- No new fundamental information provided; pipeline execution risk unchanged.
- Low institutional conviction (only 17% analyst bullish, several holders trimming).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (LKFT) — Batch item 1 | 0001171843-26-005841 |
| Document: f6k_090126.htm | 0001171843-26-005841 |
| Document: 0001171843-26-005841-index-headers.html | 0001171843-26-005841 |
| Document: 0001171843-26-005841-index.html | 0001171843-26-005841 |
| Document: 0001171843-26-005841.txt | 0001171843-26-005841 |
| 6-K Filing (LKFT) — Batch item 6 | 0001171843-26-005841 |
| Document: f6k_090126.htm | 0001171843-26-005841 |
| Document: 0001171843-26-005841-index-headers.html | 0001171843-26-005841 |
| Document: 0001171843-26-005841-index.html | 0001171843-26-005841 |
| Document: 0001171843-26-005841.txt | 0001171843-26-005841 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $30.58 | awaiting T+20 | — | $31.82 (+4.05%) |
Oct 14, 2026 12d ago | 6-K | $29.93 | awaiting T+20 | — | $31.82 (+6.31%) |
Oct 13, 2026 13d ago | 6-K | $29.40 | awaiting T+20 | — | $31.82 (+8.23%) |
Oct 6, 2026 20d ago | 6-K | $30.00 | awaiting T+20 | — | $31.82 (+6.07%) |
Sep 1, 2026 7w ago | 6-K | $28.81 $29.65 | ▲ +2.92% | ▲ +3.25% | $31.82 (+10.45%) |
Aug 25, 2026 9w ago | 6-K | $29.70 $30.72 | ▲ +3.43% | ▲ +2.46% | $31.82 (+7.14%) |
Aug 12, 2026 10w ago | 6-K | $27.93 $26.81 | ▼ −4.01% | ▼ −2.11% | $31.82 (+13.93%) |
Jul 28, 2026 12w ago | 6-K | $27.72 $29.16 | ▲ +5.19% | ▲ +0.17% | $31.82 (+14.79%) |
Jun 30, 2026 16w ago | 6-K | $29.60 $27.72 | ▼ −6.35% | ▼ −4.17% | $31.82 (+7.50%) |
Jun 24, 2026 17w ago | 6-K | $29.01 $28.78 | ▼ −0.79% | ▼ −2.73% | $31.82 (+9.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers